Addex Therapeutics Ltd ADXN
Set alert
3.09 USD +0.16 +5.46%
At close · Oct 30
3.00 -0.09 -2.86%
After hours · Oct 30, 4:00 PM ET
3.07 Day range 3.09
2.65 52-week range 9.40
- YTD
- -59.97%
- 1 year
- -66.59%
- Open
- 3.08
- Prev close
- 2.93
- Mkt cap
- 5.42M
- Vol
- 2.63K
- Avg vol
- 139.28K
- EPS
- -7.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.07
- High
- 3.09
- Forward P/E
- -159.83
- Beta
- 1.87
- Short ratio
- 0.14
- Inst. own
- 0.17%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jun 6, 2024
- 50-d avg
- 9.13
- 200-d avg
- 10.24
- 1y target
- 30.00
Financial health
Altman Z-Score
-150.56 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -0.9×
FY 2016 5y median -0.3× FY 2025
P/S 191×
FY 2016 5y median 11.2× FY 2025
P/B 1.2×
FY 2016 5y median 1.2× FY 2025
P/FCF -2.8×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -0.6×
FY 2016 5y median -0.4× FY 2025
EV/Sales 137×
FY 2016 5y median 4.3× FY 2025
FCF Yield -36.3%
FY 2016 5y median -103.5% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -9390.8%
FY 2016 5y median -681.8% FY 2025
Net Margin -22448.4%
FY 2016 5y median -654.5% FY 2025
ROE -141.1%
FY 2016 5y median -141.1% FY 2025
ROIC -54.4%
FY 2016 5y median -82.9% FY 2025
ROA -105.7%
FY 2016 5y median -105.7% FY 2025
Growth (YoY)
Revenue -92.6%
FY 2016 FY 2025
Operating Income -2.2%
FY 2016 FY 2025
EPS (diluted) -181.9%
FY 2016 FY 2025
Free Cash Flow 61.4%
FY 2016 FY 2025
Financial Health
Current Ratio 1.4×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 1.4×
FY 2016 5y median 2.4× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -1163×
FY 2016 5y median -246× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31